New Weight-Loss shot shows promise in chinese study
NCT ID NCT06256562
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 23 times
Summary
This study tested an investigational injection called GZR18 in 340 Chinese adults with obesity or overweight. Participants received either the drug or a placebo, along with diet and exercise advice. The main goal was to see how much weight they lost after 30 weeks. The study is complete, and results showed meaningful weight reduction, though ongoing management is needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Gan & Lee Pharmaceuticals Co., Ltd
Beijing, China
Conditions
Explore the condition pages connected to this study.